Adicet Bio, Inc. Capital Expenditures Incurred but Not yet Paid
Adicet Bio, Inc. (ACET) reported Capital Expenditures Incurred but Not yet Paid of $7.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:CapitalExpendituresIncurredButNotYetPaid · last filed 2026-08-05
- Adicet Bio, Inc. capital expenditures incurred but not yet paid for the quarter ending 2026-06-30 was -$157.00K, a 201.29% decline year-over-year.
- Adicet Bio, Inc. capital expenditures incurred but not yet paid for the quarter ending 2026-03-31 was $164.00K, a 26.79% decline year-over-year.
- Adicet Bio, Inc. capital expenditures incurred but not yet paid for the quarter ending 2025-12-31 was $1.00K.
- Adicet Bio, Inc. capital expenditures incurred but not yet paid for the quarter ending 2025-09-30 was -$171.00K, a 113.82% decline year-over-year.
- Adicet Bio, Inc. capital expenditures incurred but not yet paid for fiscal 2025 was $209.00K, a 85.63% decline from fiscal 2024.
- Adicet Bio, Inc. capital expenditures incurred but not yet paid for fiscal 2024 was $1.45M, a 421.15% increase from fiscal 2023.
- Adicet Bio, Inc. capital expenditures incurred but not yet paid for fiscal 2023 was $279.00K, a 50.62% decline from fiscal 2022.
- Adicet Bio, Inc. capital expenditures incurred but not yet paid for fiscal 2022 was $565.00K, a 13.21% decline from fiscal 2021.
| Period end | Capital Expenditures Incurred but Not yet Paid 3 month | Capital Expenditures Incurred but Not yet Paid 6 month | Capital Expenditures Incurred but Not yet Paid 6 month as first filed | Capital Expenditures Incurred but Not yet Paid 9 month | Capital Expenditures Incurred but Not yet Paid 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | -$157.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $7.00K 10-Q · filed 2026-08-05 | $8.00K derived: sum of 3 quarters · filed 2026-08-05 | -$163.00K derived: sum of 4 quarters · filed 2026-08-05 | |
| 2026-03-31 | $164.00K 10-Q · filed 2026-05-13 | $165.00K derived: sum of 2 quarters · filed 2026-05-13 | -$6.00K derived: sum of 3 quarters · filed 2026-05-13 | $149.00K derived: sum of 4 quarters · filed 2026-08-05 | |
| 2025-12-31 | $1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | -$170.00K derived: sum of 2 quarters · filed 2026-03-12 | -$15.00K derived: sum of 3 quarters · filed 2026-08-05 | $209.00K 10-K · filed 2026-03-12 | |
| 2025-09-30 | -$171.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | -$16.00K derived: sum of 2 quarters · filed 2026-08-05 | $208.00K 10-Q · filed 2025-11-05 | $169.00K derived: sum of 4 quarters · filed 2026-08-05 | |
| 2025-06-30 | $155.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $379.00K 10-Q · filed 2026-08-05 | $340.00K derived: sum of 3 quarters · filed 2026-08-05 | $1.58M derived: sum of 4 quarters · filed 2026-08-05 | |
| 2025-03-31 | $224.00K 10-Q · filed 2026-05-13 | $185.00K derived: sum of 2 quarters · filed 2026-05-13 | $1.42M derived: sum of 3 quarters · filed 2026-05-13 | $1.36M derived: sum of 4 quarters · filed 2026-05-13 | |
| 2024-12-31 | -$39.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | $1.20M derived: sum of 2 quarters · filed 2026-03-12 | $1.13M derived: sum of 3 quarters · filed 2026-03-12 | $1.45M 10-K · filed 2026-03-12 | |
| 2024-09-30 | $1.24M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $1.17M derived: sum of 2 quarters · filed 2025-11-05 | $1.49M 10-Q · filed 2025-11-05 | $1.67M derived: sum of 4 quarters · filed 2025-11-05 | |
| 2024-06-30 | -$64.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $256.00K 10-Q · filed 2025-08-07 | $430.00K derived: sum of 3 quarters · filed 2025-08-07 | -$135.00K derived: sum of 4 quarters · filed 2025-08-07 | |
| 2024-03-31 | $320.00K 10-Q · filed 2025-05-06 | $494.00K derived: sum of 2 quarters · filed 2025-05-06 | -$71.00K derived: sum of 3 quarters · filed 2025-05-06 | -$482.00K derived: sum of 4 quarters · filed 2025-05-06 | |
| 2023-12-31 | $174.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-06 | -$391.00K derived: sum of 2 quarters · filed 2025-03-06 | -$802.00K derived: sum of 3 quarters · filed 2025-03-06 | $279.00K 10-K · filed 2025-03-06 | |
| 2023-09-30 | -$565.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | -$976.00K derived: sum of 2 quarters · filed 2024-11-06 | $105.00K 10-Q · filed 2024-11-06 | -$6.44M derived: sum of 4 quarters · filed 2024-11-06 | |
| 2023-06-30 | -$411.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | $670.00K 10-Q · filed 2024-08-13 | -$5.88M derived: sum of 3 quarters · filed 2024-08-13 | -$3.23M derived: sum of 4 quarters · filed 2024-08-13 | |
| 2023-03-31 | $1.08M 10-Q · filed 2024-05-14 | -$5.46M derived: sum of 2 quarters · filed 2024-05-14 | -$2.82M derived: sum of 3 quarters · filed 2024-05-14 | $165.00K derived: sum of 4 quarters · filed 2024-05-14 | |
| 2022-12-31 | -$6.55M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-19 | -$3.90M derived: sum of 2 quarters · filed 2024-03-19 | -$916.00K derived: sum of 3 quarters · filed 2024-03-19 | $565.00K 10-K · filed 2024-03-19 | |
| 2022-09-30 | $2.64M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | $5.63M derived: sum of 2 quarters · filed 2023-11-08 | $7.11M 10-Q · filed 2023-11-08 | $5.18M derived: sum of 4 quarters · filed 2023-11-08 | |
| 2022-06-30 | $2.99M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | $4.47M 10-Q · filed 2023-08-09 | $2.54M derived: sum of 3 quarters · filed 2023-08-09 | $3.76M derived: sum of 4 quarters · filed 2023-08-09 | |
| 2022-03-31 | $1.48M 10-Q · filed 2023-05-09 | -$453.00K derived: sum of 2 quarters · filed 2023-05-09 | $769.00K derived: sum of 3 quarters · filed 2023-05-09 | $2.06M derived: sum of 4 quarters · filed 2023-05-09 | |
| 2021-12-31 | -$1.93M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-15 | -$712.00K derived: sum of 2 quarters · filed 2023-03-15 | $584.00K derived: sum of 3 quarters · filed 2023-03-15 | $651.00K 10-K · filed 2023-03-15 | |
| 2021-09-30 | $1.22M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | $2.52M derived: sum of 2 quarters · filed 2022-11-08 | $2.58M 10-Q · filed 2022-11-08 | $2.62M derived: sum of 4 quarters · filed 2022-11-08 | |
| 2021-06-30 | $1.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-10 | $1.36M 10-Q · filed 2022-08-10 | $1.40M derived: sum of 3 quarters · filed 2022-08-10 | $1.44M derived: sum of 4 quarters · filed 2022-08-10 | |
| 2021-03-31 | $67.00K 10-Q · filed 2022-05-12 | $106.00K derived: sum of 2 quarters · filed 2022-05-12 | $139.00K derived: sum of 3 quarters · filed 2022-05-12 | $111.00K derived: sum of 4 quarters · filed 2022-05-12 | |
| 2020-12-31 | $39.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-15 | $72.00K derived: sum of 2 quarters · filed 2022-03-15 | $44.00K derived: sum of 3 quarters · filed 2022-03-15 | $115.00K 10-K · filed 2022-03-15 | |
| 2020-09-30 | $33.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | $5.00K derived: sum of 2 quarters · filed 2021-11-10 | $76.00K 10-Q · filed 2021-11-10 | $66.00K derived: sum of 4 quarters · filed 2021-11-10 | |
| 2020-06-30 | -$28.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | $43.00K 10-Q · filed 2021-08-12 | $2.00K 10-Q · filed 2020-07-30 | $33.00K derived: sum of 3 quarters · filed 2021-08-12 | $80.00K derived: sum of 4 quarters · filed 2021-08-12 |
| 2020-03-31 | $71.00K 10-Q · filed 2021-05-17 | $61.00K derived: sum of 2 quarters · filed 2021-05-17 | $108.00K derived: sum of 3 quarters · filed 2021-05-17 | ||
| 2019-12-31 | -$10.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-12 | $37.00K derived: sum of 2 quarters · filed 2021-03-12 | $48.00K 10-K · filed 2021-03-12 | ||
| 2019-09-30 | $47.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $58.00K 10-Q · filed 2020-11-05 | |||
| 2019-06-30 | $11.00K 10-Q · filed 2020-07-30 | ||||
| 2018-12-31 | $59.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-12 | $49.00K derived: sum of 2 quarters · filed 2021-03-12 | $53.00K derived: sum of 3 quarters · filed 2021-03-12 | $61.00K 10-K · filed 2021-03-12 | |
| 2018-09-30 | -$10.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-05 | -$6.00K derived: sum of 2 quarters · filed 2019-11-05 | $2.00K 10-Q · filed 2019-11-05 | ||
| 2018-06-30 | $4.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-14 | $12.00K 10-Q · filed 2019-08-14 | |||
| 2018-03-31 | $8.00K 10-Q · filed 2019-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |